Search Results - "Newby, L"

Refine Results
  1. 1

    Inflammation as a Treatment Target after Acute Myocardial Infarction by Newby, L. Kristin

    Published in The New England journal of medicine (26-12-2019)
    “…Inflammation is widely believed to play a central role in the pathogenesis of atherosclerosis and acute coronary events. 1,2 Although treatments with proven…”
    Get full text
    Journal Article
  2. 2

    A new biomarker of acute coronary ischaemia: from bench to bedside? by Newby, L Kristin

    Published in European heart journal (13-01-2022)
    “…Graphical Abstract Graphical Abstract Bridging the gap from bench to bedside in biomarker development…”
    Get full text
    Journal Article
  3. 3

    RAS blocker effects on first HF hospitalization or CV death does not differ in Black and non-Black patients with HFrEF by Rambarat, Paula, Newby, L Kristin

    Published in Annals of internal medicine (01-10-2024)
    “…Shen L, Lee MMY, Jhund PS, et al. JAMA. 2024;331:2094-2104. 38809561…”
    Get full text
    Journal Article
  4. 4

    In higher-risk, statin-intolerant adults with diabetes, bempedoic acid reduced MACE at a median 3 y by Kelsey, Michelle, Newby, L Kristin

    Published in Annals of internal medicine (01-04-2024)
    “…Ray KK, Nicholls SJ, Li N, et al; CLEAR OUTCOMES Committees and Investigators. Lancet Diabetes Endocrinol. 2024;12:19-28. 38061370…”
    Get full text
    Journal Article
  5. 5

    Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury by DeFilippis, Andrew P, Chapman, Andrew R, Mills, Nicholas L, de Lemos, James A, Arbab-Zadeh, Armin, Newby, L Kristin, Morrow, David A

    Published in Circulation (New York, N.Y.) (12-11-2019)
    “…Although coronary thrombus overlying a disrupted atherosclerotic plaque has long been considered the hallmark and the primary therapeutic target for acute…”
    Get full text
    Journal Article
  6. 6
  7. 7

    In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy by Kelsey, Michelle D, Newby, L Kristin

    Published in Annals of internal medicine (15-12-2020)
    “…Hopewell JC, Offer A, Haynes R, et al. Eur Heart J. 2020;41:3336-42. 32702748…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y by Shadrin, Ilya Y, Newby, L Kristin

    Published in Annals of internal medicine (01-03-2024)
    “…Healey JS, Lopes RD, Granger CB, et al; ARTESIA Investigators. N Engl J Med. 2024;390:107-117. 37952132…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition by Allen, Joel D., Watanabe, Yasunori, Chawla, Himanshi, Newby, Maddy L., Crispin, Max

    Published in Journal of molecular biology (19-02-2021)
    “…[Display omitted] •N-linked glycans of ACE2 have been suggested to play a role in SARS-CoV-2 binding.•Using glycan engineering we generated a panel of glycan…”
    Get full text
    Journal Article
  14. 14
  15. 15

    High-Sensitivity Cardiac Troponin Assays: Ready for Prime Time by Krychtiuk, Konstantin A, Newby, L. Kristin

    Published in Annual review of medicine (29-01-2024)
    “…Rapid and accurate triage of patients presenting with chest pain to an emergency department (ED) is critical to prevent ED overcrowding and unnecessary…”
    Get full text
    Journal Article
  16. 16

    In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding by Tannu, Manasi, Newby, L Kristin

    Published in Annals of internal medicine (01-11-2023)
    “…Gragnano F, Cao D, Pirondini L, et al; PANTHER Collaboration. J Am Coll Cardiol. 2023;82:89-105. 37407118…”
    Get full text
    Journal Article
  17. 17

    In HF with iron deficiency, IV ferric derisomaltose was associated with lower rates of HF hospitalization or CV death by Lerman, Joseph B, Newby, L Kristin

    Published in Annals of internal medicine (01-04-2023)
    “…Kalra PR, Cleland JG, Petrie MC, et al. Lancet. 2022;400:2199-209. 36347265…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 mo by Kelsey, Michelle D, Newby, L Kristin

    Published in Annals of internal medicine (01-07-2023)
    “…Nissen SE, Lincoff MA, Brennan D, et al; CLEAR Outcomes Investigators. N Engl J Med. 2023;388:1353-1364. 36876740…”
    Get full text
    Journal Article